Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
Cancer Chemotherapy and Pharmacology
|
August 10, 2012
Phase I trial of pomalidomide given for patients with advanced solid tumors
Matthew M Cooney, Charles Nock, Joseph Bokar, et al.
American Journal of Clinical Oncology
|
December 4, 2004
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma
Cathy Eng, Ramesh K Ramanathan, Ramesh K Ramathan, et al.
The Journal of Urology
|
February 3, 2021
National Recommendations against Prostate Specific Antigen Screening versus Statewide Medicaid Expansion Initiatives: A Battle of the Titans
William C Daly, Joshua A Linscott, Paul K J Han, et al.
The Journal of Urology
|
March 18, 2021
Reply by Authors
William C Daly, Joshua A Linscott, Paul K J Han, et al.
Investigational New Drugs
|
July 22, 2005
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer
Afshin Dowlati, Robert Chapman, Shanmuga Subbiah, et al.
Investigational New Drugs
|
May 13, 2008
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles
Sharon L Sanborn, Matthew M Cooney, Afshin Dowlati, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2009
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
Afshin Dowlati, James Posey, Ramesh K Ramanathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2013
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease
Mehdi Hamadani, Laura F Gibson, Scot C Remick, et al.
Investigational New Drugs
|
November 18, 2008
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
Sharon L Sanborn, Joseph Gibbons, Smitha Krishnamurthi, et al.
Journal of the National Cancer Institute
|
May 16, 2002
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa
Mwanda W Otieno, Cecily Banura, Edward Katongole-Mbidde, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
Cancer Chemotherapy and Pharmacology
|
August 10, 2012
Phase I trial of pomalidomide given for patients with advanced solid tumors
Matthew M Cooney, Charles Nock, Joseph Bokar, et al.
American Journal of Clinical Oncology
|
December 4, 2004
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma
Cathy Eng, Ramesh K Ramanathan, Ramesh K Ramathan, et al.
The Journal of Urology
|
February 3, 2021
National Recommendations against Prostate Specific Antigen Screening versus Statewide Medicaid Expansion Initiatives: A Battle of the Titans
William C Daly, Joshua A Linscott, Paul K J Han, et al.
The Journal of Urology
|
March 18, 2021
Reply by Authors
William C Daly, Joshua A Linscott, Paul K J Han, et al.
Investigational New Drugs
|
July 22, 2005
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer
Afshin Dowlati, Robert Chapman, Shanmuga Subbiah, et al.
Investigational New Drugs
|
May 13, 2008
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles
Sharon L Sanborn, Matthew M Cooney, Afshin Dowlati, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2009
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
Afshin Dowlati, James Posey, Ramesh K Ramanathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2013
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease
Mehdi Hamadani, Laura F Gibson, Scot C Remick, et al.
Investigational New Drugs
|
November 18, 2008
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
Sharon L Sanborn, Joseph Gibbons, Smitha Krishnamurthi, et al.
Journal of the National Cancer Institute
|
May 16, 2002
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa
Mwanda W Otieno, Cecily Banura, Edward Katongole-Mbidde, et al.
Page
of 10